NCT07368998
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07368998
Title To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer (optINAVO)
Acronym optINAVO
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | GBR | ESP | BEL

Facility Status City State Zip Country Details
Los Angeles Cancer Network RECRUITING Los Angeles California 90017-4803 United States Details
Astera Cancer Care East Brunswick RECRUITING East Brunswick New Jersey 08816 United States Details
Cliniques Universitaires St-Luc RECRUITING Brussels 1200 Belgium Details
UZ Leuven Gasthuisberg RECRUITING Leuven 3000 Belgium Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona RECRUITING Barcelona 08035 Spain Details
Hospital Universitario San Cecilio RECRUITING Granada 18016 Spain Details
Hospital Universitario 12 De Octubre RECRUITING Madrid 28041 Spain Details
Hospital Clinico Universitario de Valencia RECRUITING Valencia 46010 Spain Details
Bagcilar Medipol Mega Universitesi Hastanesi RECRUITING Bağcılar Istanbul 34214 Turkey (Türkiye) Details
Adana Baskent University Hospital RECRUITING Adana 01120 Turkey (Türkiye) Details
Memorial Ankara Hastanesi RECRUITING Ankara 06520 Turkey (Türkiye) Details
Medical Park Seyhan Hospital RECRUITING Seyhan Turkey (Türkiye) Details
Princess Alexandra Hospital RECRUITING Harlow CM20 1QX United Kingdom Details
Mount Vernon Cancer Centre RECRUITING Northwood, Middlesex HA6 2RN United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field